(Press-News.org) LOS ANGELES (EMBARGOED UNTIL FEB. 9, 2011 AT 9:15 PM EST) – Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices.
The scientists created a new molecule from curcumin, a chemical component of the golden-colored spice turmeric, and found in laboratory experiments that it affects mechanisms that protect and help regenerate brain cells after stroke. Research scientist Paul A. Lapchak, Ph.D., director of Translational Research in the Department of Neurology at Cedars-Sinai Medical Center, will present these findings at the American Heart Association International Stroke Conference in Los Angeles on Wednesday, Feb. 9, at 6:15 p.m. PST.
Only one drug is now approved for ischemic stroke, which occurs when a clot blocks blood flow to the brain. Commonly called a "clot-busting drug," tissue plasminogen activator (tPA) is injected intravenously to dissolve clots and reinstate blood flow. If blood and oxygen are restored in time, consequences of the stroke, such as speech, memory, movement and other impairments, may be reduced.
The new curcumin-hybrid compound—CNB-001—does not attack clots but instead repairs stroke damage at the molecular level that feed and support the all-important brain cells, neurons.
Curcumin has been studied for its potential to treat brain injury and disease, and while the substance itself looks promising, it has several drawbacks, especially as an emergency stroke treatment, which must be quick to be effective: It is not well absorbed in the body, fails to reach its target in high concentrations, becomes depleted quickly, and is blocked from entering the brain by a natural protective mechanism called the blood-brain barrier.
"CNB-001 has many of the same benefits of curcumin but appears to be a better choice of compound for acute stroke because it crosses the blood-brain barrier, is quickly distributed in the brain, and moderates several critical mechanisms involved in neuronal survival," Lapchak says, adding that he and his colleagues expect the new drug to move to human clinical trials soon.
When brain tissue is deprived of blood and oxygen, a cascading series of interrelated events triggers at the molecular level, breaking down the normal electrical and chemical "signaling pathways" responsible for nourishing and supporting neurons. The environment quickly becomes toxic, killing brain cells and destroying their support structures.
Theoretically, interrupting these harmful events and restoring normal pathway function could prevent cell death and the memory and behavioral deficits that result, but it will take a cocktail of drugs or a drug capable of targeting many mechanisms to correct the many pathways damaged by stroke, Lapchak says. CNB-001protects brain cells from damage by repairing four major pathways. One mechanism also plays a major role in the growth and survival of neurons.
The drug reduced stroke-caused "motor deficits"—problems of muscle and movement control—in this laboratory study. It was effective when administered up to an hour after stroke, which correlates with about three hours in humans, the same time frame for which tPA is currently approved.
Lapchak and colleagues at the Salk Institute for Biological Studies used the same laboratory rabbit model to mimic human stroke that earlier researchers had employed before the clot-busting drug tPA entered clinical trials. Patrick D. Lyden, M.D., chairman of Cedars-Sinai's Department of Neurology, helped lead a major trial that resulted in the Food and Drug Administration's 1996 approval of tPA, still considered the stroke treatment gold standard.
Those who cook Indian, Thai, Malay and Persian dishes know turmeric well for its zesty flavor, use in curries and for the rich color it imparts to food. Turmeric also has a long history of use in Ayurvedic and Chinese traditional medicine.
###
Grants from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, supported the CNB-001 study (NS060685 to PAL).
Citation: American Heart Association International Stroke Conference Wednesday, Feb. 9 at 6:15 p.m
EMBARGOED UNTIL: Wednesday, February 9, 2011 at 6:15 pm Pacific Time (9:15 pm EST)
New hybrid drug, derived from common spice, may protect, rebuild brain cells after stroke
Study from Cedars-Sinai Medical Center presented at American Heart Association International Stroke Conference
2011-02-10
ELSE PRESS RELEASES FROM THIS DATE:
Simple marine worms distantly related to humans
2011-02-10
Two groups of lowly marine worms are related to complex species including vertebrates (such as humans) and starfish, according to new research. Previously thought to be an evolutionary link between simple animals such as jellyfish and the rest of animal life - the worms' surprising promotion implies that they have not always been as simple as they now appear.
Although the marine worms Xenoturbella and Acoelomorpha are very simple animals – they lack a developed nervous system or gut – they have been a source of much debate among zoologists. Acoelomorphs were reclassified ...
Memory problems may be sign of stroke risk
2011-02-10
ST. PAUL, Minn. – People who have memory problems or other declines in their mental abilities may be at higher risk for stroke, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.
"Finding ways to prevent stroke and identify people at risk for stroke are important public health problems," said study author Abraham J. Letter of the University of Alabama at Birmingham. "This study shows we might get a better idea of who is at high risk of stroke by including a couple ...
NHGRI charts course for the next phase of genomics research
2011-02-10
A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).
Molecular pathways that are implicated in single-gene disorders may hold important clues for the diagnosis and treatment ...
UK companies respond to recession by 'training smarter,' study finds
2011-02-10
Fears that most UK companies would slash investment in skills training as a result of the recession have proved to be largely unfounded, researchers at Cardiff University and the University of London have concluded. Although some employers have cut spending to the bone, total expenditure on training has reduced only slightly.
Many employers are also "training smarter", according to a new study from researchers at Cardiff University and the Centre for Learning and Life Chances in Knowledge Economies and Societies (LLAKES), at the Institute of Education, University of ...
Fetal surgery takes a huge step forward in treating children with spina bifida
2011-02-10
Performing delicate surgery in the womb, months before birth, can substantially improve outcomes for children with a common, disabling birth defect of the spine. Experts at The Children's Hospital of Philadelphia (CHOP) co-led a new landmark study showing that fetal surgery for spina bifida greatly reduces the need to divert fluid from the brain, improves mobility and improves the chances that a child will be able to walk independently.
Spina bifida is the most common birth defect of the central nervous system, affecting about 1,500 babies born each year in the United ...
Hearing with your nose: How nasal stem cells could tackle childhood hearing problems
2011-02-10
Stem Cell scientists in Australia have found that patients suffering from hearing problems which began during infancy and childhood could benefit from a transplant of stem cells from their nose. The research, published today in STEM CELLS, reveals that mucosa-derived stem cells can help preserve hearing function during the early-onset of sensorineural hearing loss.
Sensorineural hearing loss is caused by the loss of sensory cells or neurons in the cochlea, the sensory organ of the inner ear responsible for hearing. The condition can have genetic causes, often arising ...
Time to reopen PFI contracts
2011-02-10
It is time to reopen private finance initiative (PFI) contracts say leading public health physician, Professor Allyson Pollock, and colleagues on bmj.com today.
Professor Pollock, who is based at the Centre for International Public Health Policy at the University of Edinburgh, argues that "NHS PFI contracts are not good value and are endangering patient care".
Since 1997 most large-scale public capital investment in the UK has been through PFI purchasing schemes where investment banks and building companies raise the finance for public infrastructure projects.
In ...
Schools often react poorly to student suicides, experts say
2011-02-10
COLUMBUS, Ohio – Many school officials react in exactly the wrong ways when one of their students completes suicide, according to the authors of a new book.
While they may be well-intentioned, administrators who don't send the right messages may make copycat suicides more likely, and are not providing the help needed by others hurting from the tragedy.
"Without the proper knowledge and resources, many school administrators may implement strategies that could actually increase the risk of suicide among students," said Darcy Haag Granello, professor of counselor education ...
New research suggests tart cherries could speed muscle recovery
2011-02-10
Tart cherries could help athletes reduce muscle damage to recover faster from a tough workout, according to new research published in the American College of Sports Medicine's journal Medicine & Science in Sports & Exercise.
Researchers at the Sports and Exercise Science Research Center at London South Bank University in the UK gave 10 trained athletes 1 ounce of an antioxidant-packed tart cherry juice concentrate (provided by CherryActive) twice daily for seven days prior to and two days after an intense round of strength training. The athletes' recovery after the cherry ...
Motorcycle helmets reduce spine injuries after collisions
2011-02-10
Motorcycle helmets, long known to dramatically reduce the number of brain injuries and deaths from crashes, appear to also be associated with a lower risk of cervical spine injury, new research from Johns Hopkins suggests.
"We are debunking a popular myth that wearing a helmet while riding a motorcycle can be detrimental during a motorcycle crash," says study leader Adil H. Haider, M.D., M.P.H., an assistant professor of surgery at the Johns Hopkins University School of Medicine. "Using this new evidence, legislators should revisit the need for mandatory helmet laws. ...
LAST 30 PRESS RELEASES:
From camera to lab: Dr. Etienne Sibille transforms brain aging and depression research
Depression rates in LGBTQIA+ students are three times higher than their peers, new research suggests
Most parents don’t ask about firearms in the homes their kids visit
Beer-only drinkers’ diets are worse than wine drinkers
Eco-friendly biomass pretreatment method yields efficient biofuels and adsorbents
How graph convolutions amplify popularity bias for recommendation?
New lignin-based hydrogel breakthrough for wound healing and controlled drug release
Enhancing compatibility and biodegradability of PLA/biomass composites via forest residue torrefaction
Time alone heightens ‘threat alert’ in teenagers – even when connecting on social media
Study challenges long-held theories on how migratory birds navigate
Unlocking the secrets of ketosis
AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer
Making an impact. Research studies a new side of helmet safety: faceguard failures
Specific long term condition combinations have major role in NHS ‘winter pressures’
Men often struggle with transition to fatherhood amid lack of targeted information and support
More green space linked to fewer preventable deaths in most deprived areas of UK
Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma
A formula for life? New model calculates chances of intelligent beings in our Universe and beyond
Could a genetic flaw be the key to stopping people craving sugary treats?
Experts urge complex systems approach to assess A.I. risks
Fossil fuel CO2 emissions increase again in 2024
Winners of Applied Microbiology International Horizon Awards 2024 announced
A toolkit for unraveling the links between intimate partner violence, trauma and substance misuse
Can everyday physical activity improve cognitive health in middle age?
Updated guidance reaffirms CPR with breaths essential for cardiac arrest following drowning
Study reveals medical boards rarely discipline physician misinformation
New treatment helps children with rare spinal condition regain ability to walk
'Grow Your Own' teacher prep pipeline at the University of Louisiana at Lafayette funded by US Department of Education
Lab-grown human immune system uncovers weakened response in cancer patients
More than 5 million Americans would be eligible for psychedelic therapy, study finds
[Press-News.org] New hybrid drug, derived from common spice, may protect, rebuild brain cells after strokeStudy from Cedars-Sinai Medical Center presented at American Heart Association International Stroke Conference